mRNA vaccines in the rheumatologist's future
Description
CONCLUSIONS: A number of mRNA vaccines against viral pathogens are in early to late phase development. The ability to rapidly change vaccine constituents and target complex targets, make mRNA vaccines likely to be adopted in the future.
